文献速递妇科生殖医学

维生素D3对子宫内膜异位症中MDGF、EGF和PDGFB基因表达的免疫调节作用

Immunomodulatory effects of vitamin D3 on gene expression of MDGF, EGF and PDGFB in endometriosis.
PubMed 文献 · Reprod Biomed Online · 2020-05-26

研究纳入10例子宫内膜异位症女性和10例对照,取腹腔液单核细胞(PFMC)以维生素D3处理,用实时PCR检测6、24、48小时的PDGFB、MDGF和EGF基因表达。子宫内膜异位症组EGF和PDGFB表达高于对照组;维生素D3在子宫内膜异位症组显著降低EGF(6、24、48小时)、MDGF(24、48小时)和PDGFB(6小时)表达,对非子宫内膜异位症女性无显著影响。作者认为维生素D3在子宫内膜异位症中具有治疗潜力。

要点

  • 子宫内膜异位症组PFMC的EGF和PDGFB基因表达高于对照组。
  • 维生素D3在子宫内膜异位症组显著降低EGF、MDGF和PDGFB表达。
  • 维生素D3对非子宫内膜异位症女性PFMC基因表达无显著影响。

核心结论

  • 作者结论认为PDGFB和EGF基因表达在子宫内膜异位症中增加,维生素D3可显著降低该表达,提示其在子宫内膜异位症中的治疗潜力。

研究设计与样本

  • 研究纳入10例子宫内膜异位症女性和10例对照参与者,取其腹腔液单核细胞(PFMC)以维生素D3处理。
  • 于维生素D3给药后6、24和48小时用实时PCR检测PDGFB、MDGF和EGF基因表达水平。

主要发现

  • 子宫内膜异位症组PFMC的EGF和PDGFB基因表达高于对照组(分别为P = 0.006、P < 0.001)。
  • MDGF表达在子宫内膜异位症组较非子宫内膜异位症对照组有增加,但无显著差异。
  • 维生素D3在子宫内膜异位症组显著降低EGF表达,6、24、48小时分别为P < 0.001、P < 0.001、P = 0.007。
  • 维生素D3在子宫内膜异位症组显著降低MDGF表达,24、48小时分别为P < 0.001、P = 0.009。
  • 维生素D3在子宫内膜异位症组显著降低PDGFB表达,6小时P = 0.047;对非子宫内膜异位症女性PFMC基因表达无显著影响。

临床怎么用

  • 作者认为维生素D3可显著降低子宫内膜异位症中升高的PDGFB和EGF基因表达,提示其治疗潜力。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Endometriosis, an inflammatory disease, is assumed to be associated with an increased production of growth-related cytokines. Based on the emerging immunomodulatory role of vitamin D3 in different inflammatory conditions, this study aimed to examine its modulatory effect on the expression levels of the genes for platelet-derived growth factor-B (PDGFB), monocyte/macrophage-derived growth factor (MDGF, also known as PPBP) and epidermal growth factor (EGF) in peritoneal fluid mononuclear cells (PFMC) in women with and without endometriosis. DESIGN: PFMC from 10 women with endometriosis and 10 control participants were treated with vitamin D3.The gene expression levels of PDGFB, MDGF and EGF were measured 6, 24 and 48 h following vitamin D3 administration using real-time PCR. RESULTS: Gene expression levels of EGF and PDGFB were higher in the PFMC of women with endometriosis than the control group (P = 0.006, P < 0.001, respectively). Although MDGF expression showed an increase in the endometriosis group compared with non-endometriotic controls, no significant difference was found. Vitamin D3 significantly decreased EGF expression at 6, 24 and 48 h (P < 0.001, P < 0.001 and P = 0.007, respectively), MDGF at 24 and 48 h (P < 0.001 and P = 0.009, respectively) and PDGFB at 6 h (P = 0.047) in the endometriosis group. Vitamin D3 treatment had no significant effect on expression of the genes in the PFMC of non-endometriotic women. CONCLUSIONS: The study concluded that PDGFB and EGF gene expression increases in endometriosis, and vitamin D3 could markedly decrease this expression, suggesting its therapeutic potential in endometriosis.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Mohagheghian Yaghoubi H, Samadi M, Tajik N, et al. Immunomodulatory effects of vitamin D3 on gene expression of MDGF, EGF and PDGFB in endometriosis. Reprod Biomed Online. 2020. PMID: 32883565. doi:10.1016/j.rbmo.2020.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。